Introduction
Trophoblast function during implantation and placentation is essential for reproduction in mammals. Some fertility impairments or obstetric pathologies are due to a molecular level dysfunction at the materno-fetal interphase. If these alterations occur during the initial steps of pregnancy, a number of pathologies with severe consequences for pregnancy and the future development of the organism may follow. [1] [2] [3] The basic phases of trophoblast differentiation and placental development are common among species that have haemochorial placentation, such as rodents, non-human primates, and humans. 4 In rodents, placentation begins with trophoblast cell proliferation, which then forms the ectoplacental cone. The cone-derived cells then differentiate to form the labyrinth, the spongiotrophoblast layer, and the giant cell compartment. These structures constitute the foetal interface with the maternal decidua. [4] [5] [6] [7] Recently, a correlation between regulation of trophoblast functions and intracellular Stat signalling has been demonstrated. A member of this family, Signal transducers and activators of transcription 3 (STAT3), can be activated by a variety of growth factors and cytokines, which, via specific receptors, induce its phosphorylation and translocation into the nucleus. This process culminates with the transcription of several genes 8, 9 leading to an invasive trophoblast phenotype. 10 The involvement of STAT3 in the regulation of the invasive phenotype of trophoblast and choriocarcinoma cells has been confirmed by RNA interference in in vitro experiments. 11 Furthermore, the regulation of this transduction pathway depends on leukaemia inhibitory factor (LIF). 12, 13 On the other hand, LIF is present in the endometrium during implantation and decidualisation, suggesting a molecular interplay between uterus and embryo that appears to be necessary for the establishment of the maternal-fetal interface. Besides the existent knowledge concerning the regulation and activity of STAT3 in the trophoblast cell in in vitro experiments, it is little known whether these molecules and their activating signals emerge in situ during the process of trophoblastic invasion and initial placental development. Since LIF-or STAT3-deficiency leads to either infertility per implantation failure or early pregnancy loss in the murine model, much work has been dedicated to LIF and STAT3 signalling of the early pre-and postimplantation period of the mouse, 14 especially in terms of decidualisation. However, recent findings indicate that LIF and STAT3 signaling is also vital for proper placental development, mainly through control of trophoblast subset differentiation. The suppressor of cytokine signaling 3 (SOCS3), a negative regulator of STAT3, when deficient, leads to midgestational fetal demise due to placental insufficiencies secondary to maldifferentiated trophoblast subsets. It was corroborated, that this signal to differentiate was driven through LIF, since LIF receptor blockage in this model could rescue the offspring. 15, 16 For this reason, it was our objective to obtain information on STAT3 and its regulation pattern (serine activation of STAT3 and SOCS3) during main stages of murine placental development through in situ experiments at 7-14 days of pregnancy (dop). This information is crucial to help validate the hypotheses that regulation of the STAT3 signalling pathways in fact plays a role in regulating the phenotype and function of trophoblast cells. 
Materials and Methods

Animals
All experiments were conducted in accordance with the ethical principles of animal research adopted by the Brazilian College of Animal Experimentation. The study design was approved by the joint Ethics in Animal Research Committee of the Institute of Biomedical Sciences and the University of Sao Paulo (authorisation no. 115/2000). Fourteen female Swiss mice were obtained at 14 weeks of age from colonies maintained at the Animal Facilities of the Institute of Biomedical Sciences. The mice were housed in a temperature controlled environment (21±1°C), maintained at a 12-h light/dark cycle, and given free access to tap water and standard rat food Each female was housed with a male for the purpose of copulation. The vaginal plug was observed daily, and the day on which the vaginal plug was found was considered day 1 of pregnancy (term, 20 days). The mice were weighed and sacrificed on days 7 to 14 of pregnancy.
Tissue collection
The uteri samples of each pregnant mice were removed, fixed in methacarn solution (absolute methanol, chloroform, glacial acetic acid; 6:3:1) for 3 h at 4°C, and embedded in Paraplast (Oxford, St. Louis, MO, USA) at 60°C. Sections of 5 µm in thickness were cut and adhered to glass slides using 0.1% poly-LLysine (Sigma) and then dried at room temperature (25°C). Prior to the immunoreaction, some samples were stained with haematoxylin and eosin for morphological studies. Table 1 lists the antibodies used in the present study. All antibodies were polyclonal antibodies raised in rabbit. The antibody against STAT3 recognizes the molecule independent from the activation status and all splicing variants. The antibody against phospho STAT3 (Ser727) is specific for the respective phosphorylation site (all from Cell Signaling Technology, Danvers, MA, USA). The SOCS3 antibody recognizes any status of the molecule and was purchased from Santa Cruz Biotechnology (USA). The secondary antibody for detection was a biotin-conjugated goat anti-rabbit IgG (Rockland, Gilbertsville, PA, USA).
Antibodies
Immunoperoxidase procedures
Sections (5 µm) were cut, deparaffinized and rehydrated. Antigen retrieval was performed by incubating the sections in 10 mM acetate sodium buffer (pH 6.0) at 95°C for 10 min. Each of the succeeding steps was followed by a thorough rinse with PBS. All steps were performed in a humid chamber, and care was taken to avoid the desiccation of the sections. Non-specific staining was blocked by incubation with 5% of normal goat serum Original Paper 
Results
Immunoperoxidase staining STAT3
On day 7 of pregnancy, STAT3 was detected in the cytoplasm and nucleus of decidual and predecidual cells, in both, antimesometrial region ( Figure 1a ) and mesometrial region, as well as in uterine glands (Figure 1b) . Similar distribution was found on day 8 of pregnancy. On day 9, STAT3 was observed in the nucleus of giant trophoblast cells and the cytoplasm of epithelial cells of the forming new uterine lumen (Figure 1c) . By day 10 of pregnancy, STAT3 was expressed in the mesometrial decidua and cells surrounding the maternal blood vessels (Figure 1d ). In the antimesometrial region, STAT3 was only detectable in the epithelium of the new uterine lumen. By day 10, labyrinth ( Figure 1e ) and giant trophoblasts cells (Figure 1f ) could be discriminated in the placenta and both were immunoreactive for STAT3. On day 11 of pregnancy, the distribution of STAT3 in the mesometrial decidua and placental regions remains similar to the previous days. Additionally, STAT3 was expressed in the spongiotrophoblast region. This pattern of immunoreaction was maintained in placentas collected on days 12 and 14 of pregnancy, however, from day 12 onwards, the immunoreaction for STAT3 decreased in the mesometrial decidua (Figure 1f ).
Phospho-STAT3 (Ser727)
The phosphorylation of STAT3 at its serine727 residue was detectable from day 7 of pregnancy in the cytoplasm of decidual and predecidual cell of antimesometrial region as well as in the uterine glands. On days 8 and 9 of pregnancy, phospho-STAT3 (Ser727) is maintained in these regions (Figure 2a) , whereas on day 9, phosphorylation was also detected in the epithelium of the new uterine lumen (Figure 2b) .
On day 10 and 11 of pregnancy, phospho-STAT3 (Ser727) was detectable in the mesometrial decidua (Figure 2c ) and giant trophoblasts cells (Figure 2d ). On day 12 of pregnancy, phospho-STAT3 (ser727) was found in the spongiotrophoblasts region of the placenta (Figure 2e) , which was the only the positive region observed on days 13 and 14 of pregnancy (Figure 2f ).
SOCS3
On day 7 of pregnancy, SOCS3 was detectable in the cytoplasm of decidual and predecidual cells, in both antimesometrial region (Figure 3a ) and mesometrial region, as well as in the myometrium and endothelium of maternal blood vessels (Figure 3b) . In contrast Original Paper to STAT3, SOCS3 was not expressed in the uterine glands. On day 8 at 10 of pregnancy, the expression of SOCS3 was maintained, similar to the previous day. Additional immunoreaction for SOCS3 was observed in the labyrinth and giant trophoblast cells (Figure 3c ). From day 9 to day 14 of pregnancy, SOCS3 was detected in the mesometrial deciduas (Figure  3d) , endothelium of maternal blood vessel (Figure 3e ) and progressive elevation of immunoreactivity was detected in the giant trophoblast cells during these days of pregnancy (Figure 3f ).
Discussion
Previous results in mice and rat showed that STAT3 activation may be important for embryo implantation and decidualisation, and may also be regulated by maternal estrogen. [14] [15] [16] [17] . The first two days of our study timeline overlaps with the timeline of the Teng group, and our findings coincide. Embryo implantation and development demands a complex sequence of cellular and molecular modifications in the uterus. These include remodelling of the uterine lumen, synthesis and degradation of extracellular matrix (ECM), recruitment of immune-competent cells and an increasing vascular permeability. 18 Moreover, preceding embryo implantation, a wave of cell proliferation occurs in the endometrium and is followed by re-differentiation of endometrial fibroblasts into decidual cells; 19 however, the exact mechanisms of this process continue to be poorly understood.
STAT3 have been implicated in several biological processes, such as growth, differentiation, survival and apoptosis, 20 all these processes are observed during early pregnancy. The achievements of the decidual phenotype depend on several growth factors and cytokines, such as leukaemia inhibitory factor (LIF). 21 This molecule is associated with the activation of STAT3 promoting the phosphorylation and nuclear translocation of STAT3 in the mouse uterus; indicating that LIF is the principal mediator of STAT3 activation in vivo. 12 Since, as Teng et al. 14 demonstrate, also pseudopregnant mice which decidualise their tissue, also express and activate STAT3, it can be assumed that the LIF signal at this time is not originating from the embryo. Fitzgerald et al. 13 showed that LIF elicited strong tyrosine phosphorylation and specific DNA-binding activity of STAT3 in Jeg-3 choriocarcinoma cell lines, inducing a significant acceleration of cell proliferation and promoted the capability of these cells to invade into an artificial extracellular matrix. In addition we showed that STAT3 are present in trophoblast derived cells, particularly for invasive trophoblast cells, suggesting a connection between STAT3 activity and invasiveness of trophoblast cells. The inducible suppressor of cytokine signalling (Socs) proteins, are expressed in response to cytokine stimulation of Stat phosphorylation acting in a negative-feedback mechanism to hinder the activities of cytokine receptors. 22 In general, the transcription of genes encoding SOCS3 is rapidly induced by exposure to cytokines, and SOCS3 mRNA induction appears to be dependent on the activity of STAT3. 23 In our study, SOCS3 was detected in the decidua labyrinth region and the giant trophoblast cells, in a fashion the similar to STAT3 distribution. Previous study showed that in the absence of SOCS3, embryos apparently develop normally until the 10 th day of Original Paper pregnancy, but died between days 11 and 13, where the formation of spongiotrophoblast and the morphogenesis of the labyrinth are affected. 15 Takahashi et al. 16 did one in situ hybridization staining at placentas from E9.5, show SOCS3 was expressed in all trophoblast lineage including the trophoblast stem cell population in ectoplacental cone, chorion and primary giant cells. This is in correlation to our results, however we observed that 12 day onward SOCS3 was detected principally associated with giant trophoblast cells. At our part, we see that SOCS3 is generated in the trophoblast subsets starting from day 8 of pregnancy. It is appealing to hypothesize, that SOCS3 expression at this time is tolerable to a certain degree, but as the demands of fetal development increases, the placental insufficiency deriving from SOCS3 deficiency cannot be compensated for longer than E13. SOCS3 modulate the Stat signal transduction, 24 the absence of SOCS3 can be related with the maintenance of STAT3 resulting in an altered cell function.
Another mechanism geared toward maintaining balance in the Stat and MAPK system is serine phosphorylation of STAT3. The definitive function of serine phosphorylation of STAT3 is under controversy since serine phosphorylation has been seen to both boost as well as inhibit STAT3 activity. The current paradigm is that serine phospho STAT3 interferes with tyrosine phosphorylation of Stat. Serine phosphorylation is accomplished or mediated by members of several other signalling pathway families, such as (but not exclusively) ERK, MAPK, PKCdelta, mTOR, PI3K/AKT, but there is a paucity in defining which mediators enhance and which down-regulated the transcriptional activity of this protein, and which effect it has on cell function. 25 Interestingly, the serine phosphorylation of STAT3 was detected especially in the spongiotrophoblast cells of placenta starting from day 12. Coinciding to this time, it seems that fetal demise begins. It is within the range of possibility that this further signal leads to a further activation of the ERK/MAPK pathway, possibly leading to final demise of the embryo.
Finally, the balance between the expression and activation of STAT3 and its inhibitor SOCS3 could be essential for decidualisation and normal placental development in mice. 
